Pulmonary hypertension: the state of the art

Submitted: 16 July 2018
Accepted: 16 July 2018
Published: 10 September 2018
Abstract Views: 1193
PDF: 709
HTML: 182
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Pulmonary hypertension (PH) is a hemodynamic and pathophysiological condition defined as an increase in mean pulmonary arterial pressure of 25 mmHg or more at rest assessed by right heart catheterisation. It is a progressive disease characterized by high mortality and morbidity. Current PH guidelines suggest that patients with PH should be cared for in dedicated specialist centres, with expertise and resources available to provide high quality care to this fragile population. In this review, we focus on the clinical manifestations, diagnostic algorithm, risk assessment and therapeutic strategies for PH. We also provide an overview of the organisation of PH services in United Kingdom, including designation of expert centres, national audit and steps to ensure the quality and financial viability of PH care.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Dimopoulos, K., & Favoccia, C. (2018). Pulmonary hypertension: the state of the art. Italian Journal of Medicine, 12(3), 159–170. https://doi.org/10.4081/itjm.2018.1067